CJC 1295 w/o DAC

Retatrutide (also known as LY3437943) is an investigational synthetic peptide developed by Eli Lilly. It is a triple receptor agonist designed to simultaneously activate three key hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon (GCGR).

MOL. WT.

30mg

PURITY

99.8%

BATCH#

DG-20260707PPR

Hurry! This sale ends in

Guaranteed Safe Checkout

Product Description:

CJC-1295 without DAC is a synthetic growth hormone–releasing hormone analog studied for its interaction with GHRH receptor signaling pathways. Research involving CJC-1295 w/o DAC has focused on pituitary signaling, growth hormone pulse modulation, and downstream IGF-1–related mechanisms.

Product Details
Name: CJC-1295 w/o DAC
Also known as: Modified GRF 1-29
Form: Lyophilized powder
Size: 10mg
Category: GHRH analog research peptide
Use: Laboratory research use only
Storage: Store refrigerated and protected from light

Notice: Not for human consumption. Not for medical, veterinary, diagnostic, therapeutic, or cosmetic use.

Customer Reviews

Reviews

There are no reviews yet.

Be the first to review “CJC 1295 w/o DAC”

Your email address will not be published. Required fields are marked *